Patents by Inventor Bhaskar Rege

Bhaskar Rege has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR CANCER IMMUNOTHERAPY
    Publication number: 20250032582
    Abstract: The disclosure provides compositions and improved methods for the treatment of cancer comprising administering to a patient the fusion protein of SEQ ID NO: 1 at a less frequent dosing schedule (i.e., a single administration every three weeks or multiple administrations on non-consecutive days).
    Type: Application
    Filed: February 10, 2023
    Publication date: January 30, 2025
    Applicant: Mural Oncology, Inc.
    Inventors: Rita Dalal, Lei Sun, Bhaskar Rege, Jessicca Rege
  • PHARMACEUTICAL COMPOSITION COMPRISING PDE9 INHIBITOR
    Publication number: 20220378706
    Abstract: The present invention provides a pharmaceutical composition comprising a PDE9 inhibitor. Specifically, the PDE9 inhibitor is (S)-7-(2-methoxy-3,5-dimethylpyridin-4-yl)-1-(tetrahydrofuran-3-yl)-1H-pyrazolo[4,3-c]quin olin-4(5H)-one or pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: June 3, 2022
    Publication date: December 1, 2022
    Applicant: Eisai R&D Management Co., Ltd.
    Inventors: Edgar Schuck, Robert Lai, Ishani Savant Landry, Bhaskar Rege, Mai Miyamoto, Sadaharu Kotani, Kanta Horie
  • Pharmaceutical composition comprising PDE9 inhibitor
    Patent number: 11484502
    Abstract: The present invention provides a pharmaceutical composition comprising a PDE9 inhibitor. Specifically, the PDE9 inhibitor is (S)-7-(2-methoxy-3,5-dimethylpyridin-4-yl)-1-(tetrahydrofuran-3-yl)-1H-pyrazolo[4,3-c]quin olin-4(5H)-one or pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: May 30, 2018
    Date of Patent: November 1, 2022
    Assignee: Eisai R&D Management Co., Ltd.
    Inventors: Edgar Schuck, Robert Lai, Ishani Savant Landry, Bhaskar Rege, Mai Miyamoto, Sadaharu Kotani, Kanta Horie
  • PHARMACEUTICAL COMPOSITION COMPRISING PDE9 INHIBITOR
    Publication number: 20200078306
    Abstract: The present invention provides a pharmaceutical composition comprising a PDE9 inhibitor. Specifically, the PDE9 inhibitor is (S)-7-(2-methoxy-3,5-dimethylpyridin-4-yl)-1-(tetrahydrofuran-3-yl)-1H-pyrazolo[4,3-c]quin olin-4(5H)-one or pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: May 30, 2018
    Publication date: March 12, 2020
    Applicant: Eisai R&D Management Co., Ltd.
    Inventors: Edgar Schuck, Robert Lai, Ishani Savant Landry, Bhaskar Rege, Mai Miyamoto, Sadaharu Kotani, Kanta Horie